# Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

> **NCT00862420** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 431 (actual)

## Conditions studied

- Peripheral Arterial Disease (PAD)

## Interventions

- **DRUG:** clopidogrel (SR25990)
- **DRUG:** ticlopidine

## Key facts

- **NCT ID:** NCT00862420
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 431 (ACTUAL)
- **Last updated:** 2012-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862420, "Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00862420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*